Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Pharmacovigilance (PV) Outsourcing market report explains the definition, types, applications, major countries, and major players of the Pharmacovigilance (PV) Outsourcing market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Ergomed
Covance
SIRO Clinpharm
Symogen
Novartis
PrimeVigilance
Pure Drug Safety
Deloitte Touche Tohmatsu Limited
IQVIA
Oracle Corporation
Clintec
C3i Solutions
Accenture
iMED Global Corporation
PharmInvent
iGATE Corporation
ELC Group
Parexel
MarksMan Healthcare
Sciformix
Medpace Holdings
By Type:
Contract Research Organizations (CROs)
Business Process Outsourcing (BPOs)
By End-User:
Premarketing Clinical Trial
Post-marketing Clinical Practice
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Pharmacovigilance (PV) Outsourcing Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Pharmacovigilance (PV) Outsourcing Outlook to 2028- Original Forecasts
-
2.2 Pharmacovigilance (PV) Outsourcing Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Pharmacovigilance (PV) Outsourcing Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Pharmacovigilance (PV) Outsourcing Market- Recent Developments
-
6.1 Pharmacovigilance (PV) Outsourcing Market News and Developments
-
6.2 Pharmacovigilance (PV) Outsourcing Market Deals Landscape
7 Pharmacovigilance (PV) Outsourcing Raw Materials and Cost Structure Analysis
-
7.1 Pharmacovigilance (PV) Outsourcing Key Raw Materials
-
7.2 Pharmacovigilance (PV) Outsourcing Price Trend of Key Raw Materials
-
7.3 Pharmacovigilance (PV) Outsourcing Key Suppliers of Raw Materials
-
7.4 Pharmacovigilance (PV) Outsourcing Market Concentration Rate of Raw Materials
-
7.5 Pharmacovigilance (PV) Outsourcing Cost Structure Analysis
-
7.5.1 Pharmacovigilance (PV) Outsourcing Raw Materials Analysis
-
7.5.2 Pharmacovigilance (PV) Outsourcing Labor Cost Analysis
-
7.5.3 Pharmacovigilance (PV) Outsourcing Manufacturing Expenses Analysis
8 Global Pharmacovigilance (PV) Outsourcing Import and Export Analysis (Top 10 Countries)
-
8.1 Global Pharmacovigilance (PV) Outsourcing Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Pharmacovigilance (PV) Outsourcing Export by Region (Top 10 Countries) (2017-2028)
9 Global Pharmacovigilance (PV) Outsourcing Market Outlook by Types and Applications to 2022
-
9.1 Global Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Contract Research Organizations (CROs) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Business Process Outsourcing (BPOs) Consumption and Growth Rate (2017-2022)
-
9.2 Global Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Premarketing Clinical Trial Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Post-marketing Clinical Practice Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Pharmacovigilance (PV) Outsourcing Market Analysis and Outlook till 2022
-
10.1 Global Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.2.2 Canada Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.2.3 Mexico Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.2 UK Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.3 Spain Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.4 Belgium Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.5 France Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.6 Italy Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.7 Denmark Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.8 Finland Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.9 Norway Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.10 Sweden Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.11 Poland Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.12 Russia Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.3.13 Turkey Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.2 Japan Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.3 India Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.4 South Korea Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.5 Pakistan Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.6 Bangladesh Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.7 Indonesia Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.8 Thailand Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.9 Singapore Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.10 Malaysia Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.11 Philippines Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.4.12 Vietnam Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.2 Colombia Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.3 Chile Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.4 Argentina Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.5 Venezuela Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.6 Peru Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.7 Puerto Rico Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.5.8 Ecuador Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.6.2 Kuwait Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.6.3 Oman Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.6.4 Qatar Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.6.5 Saudi Arabia Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.6.6 United Arab Emirates Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.7.2 South Africa Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.7.3 Egypt Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.7.4 Algeria Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
-
10.8.2 New Zealand Pharmacovigilance (PV) Outsourcing Consumption (2017-2022)
11 Global Pharmacovigilance (PV) Outsourcing Competitive Analysis
-
11.1 Ergomed
-
11.1.1 Ergomed Company Details
-
11.1.2 Ergomed Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Ergomed Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.1.4 Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Covance
-
11.2.1 Covance Company Details
-
11.2.2 Covance Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Covance Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.2.4 Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 SIRO Clinpharm
-
11.3.1 SIRO Clinpharm Company Details
-
11.3.2 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.3.4 SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Symogen
-
11.4.1 Symogen Company Details
-
11.4.2 Symogen Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Symogen Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.4.4 Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Novartis
-
11.5.1 Novartis Company Details
-
11.5.2 Novartis Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Novartis Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.5.4 Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 PrimeVigilance
-
11.6.1 PrimeVigilance Company Details
-
11.6.2 PrimeVigilance Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 PrimeVigilance Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.6.4 PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Pure Drug Safety
-
11.7.1 Pure Drug Safety Company Details
-
11.7.2 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.7.4 Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Deloitte Touche Tohmatsu Limited
-
11.8.1 Deloitte Touche Tohmatsu Limited Company Details
-
11.8.2 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.8.4 Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 IQVIA
-
11.9.1 IQVIA Company Details
-
11.9.2 IQVIA Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 IQVIA Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.9.4 IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Oracle Corporation
-
11.10.1 Oracle Corporation Company Details
-
11.10.2 Oracle Corporation Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Oracle Corporation Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.10.4 Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Clintec
-
11.11.1 Clintec Company Details
-
11.11.2 Clintec Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Clintec Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.11.4 Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 C3i Solutions
-
11.12.1 C3i Solutions Company Details
-
11.12.2 C3i Solutions Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 C3i Solutions Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.12.4 C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 Accenture
-
11.13.1 Accenture Company Details
-
11.13.2 Accenture Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 Accenture Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.13.4 Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 iMED Global Corporation
-
11.14.1 iMED Global Corporation Company Details
-
11.14.2 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.14.4 iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 PharmInvent
-
11.15.1 PharmInvent Company Details
-
11.15.2 PharmInvent Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 PharmInvent Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.15.4 PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.15.5 Recent Research and Development Strategies
-
11.16 iGATE Corporation
-
11.16.1 iGATE Corporation Company Details
-
11.16.2 iGATE Corporation Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.16.3 iGATE Corporation Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.16.4 iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.16.5 Recent Research and Development Strategies
-
11.17 ELC Group
-
11.17.1 ELC Group Company Details
-
11.17.2 ELC Group Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.17.3 ELC Group Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.17.4 ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.17.5 Recent Research and Development Strategies
-
11.18 Parexel
-
11.18.1 Parexel Company Details
-
11.18.2 Parexel Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.18.3 Parexel Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.18.4 Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.18.5 Recent Research and Development Strategies
-
11.19 MarksMan Healthcare
-
11.19.1 MarksMan Healthcare Company Details
-
11.19.2 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.19.3 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.19.4 MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.19.5 Recent Research and Development Strategies
-
11.20 Sciformix
-
11.20.1 Sciformix Company Details
-
11.20.2 Sciformix Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.20.3 Sciformix Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.20.4 Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.20.5 Recent Research and Development Strategies
-
11.21 Medpace Holdings
-
11.21.1 Medpace Holdings Company Details
-
11.21.2 Medpace Holdings Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
11.21.3 Medpace Holdings Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
11.21.4 Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
-
11.21.5 Recent Research and Development Strategies
12 Global Pharmacovigilance (PV) Outsourcing Market Outlook by Types and Applications to 2028
-
12.1 Global Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Contract Research Organizations (CROs) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Business Process Outsourcing (BPOs) Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Premarketing Clinical Trial Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Post-marketing Clinical Practice Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Pharmacovigilance (PV) Outsourcing Market Analysis and Outlook to 2028
-
13.1 Global Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.2.2 Canada Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.2.3 Mexico Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.2 UK Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.3 Spain Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.4 Belgium Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.5 France Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.6 Italy Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.7 Denmark Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.8 Finland Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.9 Norway Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.10 Sweden Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.11 Poland Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.12 Russia Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.3.13 Turkey Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.2 Japan Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.3 India Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.4 South Korea Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.8 Thailand Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.9 Singapore Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.11 Philippines Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.2 Colombia Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.3 Chile Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.4 Argentina Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.6 Peru Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.6.3 Oman Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.6.4 Qatar Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.7.2 South Africa Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.7.3 Egypt Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.7.4 Algeria Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Pharmacovigilance (PV) Outsourcing Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Pharmacovigilance (PV) Outsourcing
-
Figure of Pharmacovigilance (PV) Outsourcing Picture
-
Table Global Pharmacovigilance (PV) Outsourcing Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Pharmacovigilance (PV) Outsourcing Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Contract Research Organizations (CROs) Consumption and Growth Rate (2017-2022)
-
Figure Global Business Process Outsourcing (BPOs) Consumption and Growth Rate (2017-2022)
-
Figure Global Premarketing Clinical Trial Consumption and Growth Rate (2017-2022)
-
Figure Global Post-marketing Clinical Practice Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Table North America Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure United States Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Canada Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Mexico Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table Europe Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure Germany Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure UK Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Spain Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Belgium Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure France Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Italy Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Denmark Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Finland Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Norway Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Sweden Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Poland Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Russia Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Turkey Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table APAC Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure China Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Japan Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure India Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Thailand Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Singapore Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Philippines Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table South America Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure Brazil Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Colombia Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Chile Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Argentina Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Peru Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table GCC Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure Bahrain Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Oman Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Qatar Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table Africa Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure Nigeria Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure South Africa Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Egypt Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure Algeria Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table Oceania Pharmacovigilance (PV) Outsourcing Consumption by Country (2017-2022)
-
Figure Australia Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Pharmacovigilance (PV) Outsourcing Consumption and Growth Rate (2017-2022)
-
Table Ergomed Company Details
-
Table Ergomed Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Ergomed Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Ergomed Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Covance Company Details
-
Table Covance Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Covance Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Covance Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table SIRO Clinpharm Company Details
-
Table SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table SIRO Clinpharm Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Symogen Company Details
-
Table Symogen Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Symogen Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Symogen Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Novartis Company Details
-
Table Novartis Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Novartis Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table PrimeVigilance Company Details
-
Table PrimeVigilance Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table PrimeVigilance Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table PrimeVigilance Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Pure Drug Safety Company Details
-
Table Pure Drug Safety Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pure Drug Safety Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Pure Drug Safety Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Deloitte Touche Tohmatsu Limited Company Details
-
Table Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Deloitte Touche Tohmatsu Limited Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table IQVIA Company Details
-
Table IQVIA Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table IQVIA Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table IQVIA Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Oracle Corporation Company Details
-
Table Oracle Corporation Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Oracle Corporation Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Oracle Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Clintec Company Details
-
Table Clintec Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Clintec Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Clintec Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table C3i Solutions Company Details
-
Table C3i Solutions Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table C3i Solutions Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table C3i Solutions Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Accenture Company Details
-
Table Accenture Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Accenture Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Accenture Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table iMED Global Corporation Company Details
-
Table iMED Global Corporation Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table iMED Global Corporation Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table iMED Global Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table PharmInvent Company Details
-
Table PharmInvent Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table PharmInvent Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table PharmInvent Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table iGATE Corporation Company Details
-
Table iGATE Corporation Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table iGATE Corporation Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table iGATE Corporation Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table ELC Group Company Details
-
Table ELC Group Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table ELC Group Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table ELC Group Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Parexel Company Details
-
Table Parexel Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Parexel Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Parexel Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table MarksMan Healthcare Company Details
-
Table MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table MarksMan Healthcare Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Sciformix Company Details
-
Table Sciformix Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sciformix Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Sciformix Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Table Medpace Holdings Company Details
-
Table Medpace Holdings Pharmacovigilance (PV) Outsourcing Sales, Price, Value and Gross Profit (2017-2022)
-
Table Medpace Holdings Pharmacovigilance (PV) Outsourcing Main Business and Markets Served
-
Table Medpace Holdings Pharmacovigilance (PV) Outsourcing Product Portfolio
-
Figure Global Contract Research Organizations (CROs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Business Process Outsourcing (BPOs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Premarketing Clinical Trial Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Post-marketing Clinical Practice Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Table North America Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure United States Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure Germany Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure China Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure Brazil Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Pharmacovigilance (PV) Outsourcing Consumption Forecast by Country (2022-2028)
-
Figure Australia Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Pharmacovigilance (PV) Outsourcing Consumption Forecast and Growth Rate (2022-2028)
-
